Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Shares Issued (2016 - 2025)

Bio-Techne (TECH) has 17 years of Shares Issued data on record, last reported at $4.7 million in Q4 2025.

  • For Q4 2025, Shares Issued fell 14.46% year-over-year to $4.7 million; the TTM value through Dec 2025 reached $49.3 million, down 31.39%, while the annual FY2025 figure was $51.7 million, 15.09% down from the prior year.
  • Shares Issued reached $4.7 million in Q4 2025 per TECH's latest filing, down from $23.5 million in the prior quarter.
  • Across five years, Shares Issued topped out at $37.9 million in Q3 2021 and bottomed at $4.4 million in Q1 2023.
  • Average Shares Issued over 5 years is $14.0 million, with a median of $11.9 million recorded in 2022.
  • Peak YoY movement for Shares Issued: crashed 73.0% in 2022, then skyrocketed 314.54% in 2024.
  • A 5-year view of Shares Issued shows it stood at $18.6 million in 2021, then plummeted by 73.0% to $5.0 million in 2022, then rose by 4.95% to $5.3 million in 2023, then grew by 5.0% to $5.5 million in 2024, then fell by 14.46% to $4.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $4.7 million in Q4 2025, $23.5 million in Q3 2025, and $6.2 million in Q2 2025.